Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase Ib combination trial of AEG 40826 in cancer

Trial Profile

Phase Ib combination trial of AEG 40826 in cancer

Planning
Phase of Trial: Phase I

Latest Information Update: 24 Dec 2012

At a glance

  • Drugs AEG 40826 (Primary)
  • Indications Cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 24 Dec 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top